Search results for "Prednisolone"

showing 10 items of 112 documents

A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis

2002

Objective - To investigate the efficacy of two different high doses of intravenous methylprednisolone (IVMP) during Multiple Sclerosis (MS) relapses. Background - Transcranial Magnetic Stimulation (TMS) is the most sensitive neurophysiological ascertainment to quantify motor disability, to follow the recovery from an MS relapse, and to detect the response to treatment. Design and method - Twenty-four clinically definite relapsing - remitting MS patients presenting a relapse were randomly assigned to a treatment for 5 days with IVMP 1 or 2 g/day. The response to treatment of each patient was evaluated through Expanded Disability Status Scale (EDSS), Medical Research Council (MRC) score, and …

Neuroscience (all)High dose methylprednisoloneMultiple sclerosiSettore MED/26 - NeurologiaNeurology (clinical)Randomized trialTranscranial magnetic stimulation
researchProduct

Response to initial treatment of multisystem langerhans cell histiocytosis: An important prognostic indicator

2002

Background Reliable prediction of prognosis allowing risk-adapted therapy remains a major issue in the management of multisystem Langerhans cell histiocytosis (LCH). In a recent publication of the International LCH Study Group, response to initial therapy appears to be a reliable outcome predictor. The aim of this study is to test this observation in a cohort of patients treated with more intensive initial therapy. Furthermore, we compare the predictive value of response to initial therapy to some other well-established stratification systems. Procedure Response to initial combination chemotherapy (prednisolone, vinblastine, and etoposide) at 6 weeks and its prognostic value was evaluated r…

OncologyCancer Researchmedicine.medical_specialtybusiness.industryRetrospective cohort studyCombination chemotherapymedicine.diseaseSurgeryHistiocytosisPharmacotherapyOncologyLangerhans cell histiocytosisInternal medicinePediatrics Perinatology and Child HealthCohortmedicinePrednisolonebusinessSurvival ratemedicine.drugMedical and Pediatric Oncology
researchProduct

Treatment of pemphigus vulgaris with mycophenolate mofetil

1997

different pattern of diffusion changes in a 51-year-old woman with chronic epilepsy and recurrent episodes of focal status epilepticus, for whom no aetiology could be established. Status consisted of clonic jerking of the right leg, which continued for 22 days and was followed by transient paresis. DWI during status showed decreased diffusion in the motor cortex of the right leg (relative decrease in ADC of 27%, see figure). Surprisingly, the diffusion was increased in the subcortical white matter (relative increase in ADC of 31%). On the T2-weighted image (not shown), both cortex and subcortical white matter of the corresponding region returned a high signal similar to previously reported …

Pathologymedicine.medical_specialtyPrednisoloneAnti-Inflammatory AgentsMycophenolateMycophenolic acidWhite matterIMP DehydrogenaseCortex (anatomy)medicineHumansPremovement neuronal activityParesisbusiness.industryRemission InductionPemphigus vulgarisGeneral MedicineMycophenolic Acidmedicine.diseasemedicine.anatomical_structureDrug Therapy Combinationmedicine.symptombusinessImmunosuppressive AgentsPemphigusmedicine.drugMotor cortexThe Lancet
researchProduct

Successful treatment of adult multisystemic Langerhans cell histiocytosis with psoralen-UV-A, prednisolone, mercaptopurine, and vinblastine.

2008

Background Langerhans cell histiocytosis (LCH) is a rare disease with a peak incidence in childhood. There is limited experience with treatment options for adult patients having multisystemic LCH involvement. We report successful treatment of a 70-year-old woman with adult onset of LCH and multisystem disease (diabetes insipidus centralis, bone marrow infiltration, and lung and skin involvement). Observations A 70-year-old woman with erythematous plaques and papules of the submammary and inguinal skin attended our outpatient clinic and was diagnosed as having LCH. Organ involvement was found in the infundibulum of the pituitary gland, associated with diabetes insipidus centralis, bone marro…

Pathologymedicine.medical_specialtyPrednisoloneDermatologyVinblastineUltraviolet therapyLangerhans cell histiocytosisBone MarrowMedicineOutpatient clinicHumansGlucocorticoidsLungHistiocyteAgedSkinPhotosensitizing Agentsbusiness.industryFicusinGeneral Medicinemedicine.diseaseMercaptopurineMagnetic Resonance ImagingHistiocytosisHistiocytosis Langerhans-CellTreatment OutcomePituitary GlandImmunologyDiabetes insipidusPrednisoloneDrug Therapy CombinationFemaleUltraviolet TherapybusinessTomography X-Ray Computedmedicine.drugFollow-Up StudiesArchives of dermatology
researchProduct

Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: two case reports

2017

Abstract Background Anti-N-methyl-D-aspartate receptor encephalitis is a rare autoimmune disease characterized by severe neurological and psychiatric symptoms and a difficult diagnosis. The disease is often secondary to a neoplastic lesion, seldom diagnosed years later. Psychiatric symptoms are prevalent in adults; neurologic symptoms are more evident in children, who typically present primarily with neurological symptoms. To the best of our knowledge, the association with juvenile idiopathic arthritis has not been described. Case presentation We report the cases of two caucasian girls with an atypical presentation. The first patient was an 8-year-old girl with normal psychomotor developmen…

PediatricsPathologyChoreiform movementAnti-Inflammatory AgentsArthritislcsh:MedicineCase ReportDisease0302 clinical medicinePrednisoneChildOvarian Neoplasms030219 obstetrics & reproductive medicineMedicine (all)Remission InductionTeratomaImmunoglobulins IntravenousGeneral MedicineMagnetic Resonance ImagingTreatment OutcomeMethylprednisoloneFemaleHip JointTeratomamedicine.symptomEncephalitismedicine.drugmedicine.medical_specialtyAdolescentAnti-N-methyl-D-aspartate receptor encephalitis; Chorea; Juvenile idiopathic arthritis; Psychiatric symptoms; Speech disorders; Teratoma; Medicine (all)Methylprednisolone03 medical and health sciencesJuvenile idiopathic arthritiChoreaPsychiatric symptomsmedicineHumansImmunologic FactorsAnti-N-methyl-D-aspartate receptor encephalitis; Chorea; Juvenile idiopathic arthritis; Psychiatric symptoms; Speech disorders; TeratomaAnti-N-methyl-D-aspartate receptor encephalitis; Chorea; Juvenile idiopathic arthritis; Psychiatric symptoms; Speech disorders; Teratoma; Adolescent; Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Arthritis Infectious; Child; Female; Hip Joint; Humans; Immunoglobulins Intravenous; Immunologic Factors; Magnetic Resonance Imaging; Methylprednisolone; Ovarian Neoplasms; Remission Induction; Teratoma; Treatment Outcome; Medicine (all)Speech disorderSpeech disordersArthritis InfectiousPsychiatric symptombusiness.industrylcsh:RChoreaJuvenile idiopathic arthritismedicine.diseaseAnti-N-methyl-D-aspartate receptor encephalitisbusiness030217 neurology & neurosurgeryAnti-N-methyl-D-aspartate receptor encephaliti
researchProduct

Glucocorticoids in Graves’ orbitopathy: mechanisms of action and clinical application

2020

Background:Graves’ orbitopathy (GO) is the most frequent extrathyroidal manifestation of the autoimmune Graves’ disease. GO significantly impacts quality of life and has a psycho-social morbidity. Inflammation and swelling of the orbital tissue often leads to proptosis, diplopia, and decrease of visual acuity. Due to the inflammatory background of the disease, glucocorticoids (GC) have been used as a first-line treatment for decades.Methods:PubMed and MeSH database were searched for original articles, clinical trials, reviews, and meta-analyses published between 1 January 2000 and 31 March 2020 and pertaining to both the mechanism of action and immunological effects of GC as well as to the …

Pediatricsmedicine.medical_specialtylcsh:RC648-665glucocorticoidsIntravenous methylprednisolonebusiness.industryGraves’ orbitopathyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismReviewthyroid eye diseaseDiseaselcsh:Diseases of the endocrine glands. Clinical endocrinologyintravenous methylprednisolonepharmacology immunologymechanisms of action03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Action (philosophy)030221 ophthalmology & optometrymedicinebusinessTherapeutic Advances in Endocrinology and Metabolism
researchProduct

Die Beeinflussung eines experimentellen Stauungs�dems der Ratte durch Chlorothiazid, Hydrocortison, Dexamethason, DOCA und Vasopressin

1960

Experiments on rats were made to determine which drugs were capable of preventing the formation of an experimental obstruction edema.

PharmacologyVasopressinmedicine.medical_specialtybusiness.industryeducationPharmacology toxicologyGeneral Medicineurologic and male genital diseasesEndocrinologyEdemaInternal medicinemedicinePrednisolonemedicine.symptombusinessDexamethasoneChlorothiazideHydrocortisonemedicine.drugNaunyn-Schmiedeberg's Archiv f�r Experimentelle Pathologie und Pharmakologie
researchProduct

Use of a clinicoradiological score to determine the presurgical diagnosis of autoimmune hypophysitis in a teenage girl.

2013

The distinction between autoimmune hypophysitis and other non–hormone secreting pituitary masses is often difficult to determine with certainty without pituitary biopsy and pathological examination. To aid in this distinction, the authors recently published a clinicoradiological scoring system, which they used in the case of a 15-year-old girl presented here. The patient presented with headache, visual field defects, polydipsia, and polyuria, and she was found to have secondary hypogonadism and hypoadrenalism. Magnetic resonance imaging showed a pituitary mass of approximately 2 cm in diameter. Application of the clinicoradiological parameters gave a score of −6, which favored a diagnosis o…

Pituitary glandmedicine.medical_specialtyPathologyAdenomaAdolescentHypophysitisPrednisoloneAnti-Inflammatory AgentsHypopituitarismHypopituitarismAutoimmune DiseasesPolyuriaHypoadrenalismmedicineHumansbusiness.industryHeadacheGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingRadiographyPituitary Hormonesmedicine.anatomical_structureTreatment OutcomePituitary GlandAutoimmune hypophysitisPrednisoloneFemaleRadiologymedicine.symptombusinessmedicine.drugJournal of neurosurgery. Pediatrics
researchProduct

Investigations on the Mechanism of Induction of the Alkaline Phosphatase by Bromodesoxyuridine in Herpes simplex Virus Transformed Cells and the Tran…

1980

Addition of BrdUrd in combination with prednisolone to HSVi-transformed hamster embryo cells induces an alkaline phosphatase (AP). FdUrd enhances, dThd reduces the inducing capacity of BrdUrd and prednisolone. Induction is prevented by addition of cycloheximide or of cytosine arabinoside. BrdUrd reduces transport and phosphorylation of exogenously applied labeled Urd, especially the amount of UTP, UDP and Urd-diphosphate sugars. The Lineweaver-Burk-plot of uridine-up­take after addition of BrdUrd reveales the characteristics of the mixed type inhibition (competi­tive-noncompetitive).

PrednisoloneHamsterCycloheximidemedicine.disease_causeGeneral Biochemistry Genetics and Molecular Biologychemistry.chemical_compoundCricetinaemedicineAnimalsSimplexvirusCycloheximideUridineCells CulturedBiological TransportEmbryoAlkaline PhosphataseCell Transformation ViralEmbryo MammalianUridineKineticsHerpes simplex virusBromodeoxyuridinechemistryBiochemistryEnzyme InductionPhosphorylationAlkaline phosphataseCytosineZeitschrift für Naturforschung C
researchProduct

Hypersensitivity pneumonitis : Lessons from a randomized controlled trial in children

2021

Introduction Hypersensitivity pneumonitis (HP) in children is a severe interstitial lung disease and potentially, a chronic condition, if not treated appropriately. No evidence-based guidelines are available; in particular, the role of systemic glucocorticoid therapy is unclear. Methods The aim of this randomized, double-blind, placebo-controlled, parallel-group, multi-center, phase II trial in pediatric HP was to assess the outcome of HP in children after 6 months of treatment and to compare 3 months of treatment with oral prednisolone or placebo. Results After 1.5 years and the inclusion of only four children, we terminated the study prematurely. Two of the children randomized to predniso…

Pulmonary and Respiratory MedicineAdultChronic conditionPediatricsmedicine.medical_specialtyPrednisoloneMedizinPlacebolaw.inventionFEV1/FVC ratioRandomized controlled trialDouble-Blind MethodlawMedicineHumansChildGlucocorticoidsbusiness.industryInterstitial lung diseasemedicine.diseaseClinical trialPediatrics Perinatology and Child HealthPrednisolonebusinessLung Diseases InterstitialHypersensitivity pneumonitismedicine.drugAlveolitis Extrinsic Allergic
researchProduct